Loading asset research
Bicara Therapeutics Inc. Common Stock
BCAXNasdaq · USD · StocksQuote as of · Exchange session not verified$22.83
-1.17%
Today
BCAX
Loading 1D prices…
Market cap
$1.5B
Volume
471.5K
52w high
$30.9952w low
$10.30Company profile
Bicara Therapeutics Inc. Common Stock
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Boston, MA, United States
Employees
103
Fiscal year end
1231
CIK
2023658
Session & valuation
Open$23.29
Previous close$23.10
Day high$24.23
Day low$22.40
30-day avg. volume602.3K
Outstanding shares66.2M
Diluted EPS-$2.52
Latest annual period
P/E (trailing)-9.06
P/E (forward)-6.58
Price / book3.21
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| AAPGAscentage Pharma Group International American Depository Shares | $1.5B | — | — | -$13.96 | -3.42% | Buy |
| INVAInnoviva Inc. Common Stock | $1.5B | $411.3M | +65.92% | $3.30 | +0.19% | Hold |
| AVLNAvalyn Pharma Inc. Common Stock | $1.5B | $0.00 | — | -$2.04 | -3.00% | Buy |
| LTGOLatigo Biotherapeutics Inc. Common Stock | $1.5B | $0.00 | — | -$2.48 | +2.69% | Buy |
| PAHCPhibro Animal Health Corporation Class A Common Stock | $1.4B | $1.5B | +6.57% | $2.43 | -2.60% | Hold |